{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:39:06Z","timestamp":1791229146670,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The aim of this study was to evaluate the health status of children cured from hepatoblastoma. Forty-five patients with hepatoblastoma treated between 1996\u20132014 were assessed. The recorded data included sex, age at diagnosis, disease stage, treatment methods, time since diagnosis, and the evaluation of health status domains which included performance status, growth development, hearing, cardiovascular, skeletal, gastrointestinal, genitourinary, neurological, and hematological function. There were 30 boys and 15 girls. The age at diagnosis ranged from one month to 14 years (median one year). At the time of the health status evaluation, the youngest patient was 5.5 years old and the oldest was 21 years of age (median\u201410 years). All patients were treated according to the Childhood Liver Tumors Strategy Group\u2014SIOPEL recommendations, though they were not active participants of the studies. The median cumulative dose of cisplatin was 520 mg\/m2 and 360 mg\/m2 for doxorubicin. Thirty-six patients underwent partial hepatectomy, and nine total hepatectomy and liver transplantation. At a median of nine years from diagnosis, 68% of hepatoblastoma survivors had experienced at least one chronic health condition of any grade. The most frequent late complication was ototoxicity (28.8%), and the most serious were second malignancies (6.6%) and cardiomyopathy (4.4%). Conclusion: Survivors of hepatoblastoma are at risk for long-term complications. They require long-term monitoring for late effects.<\/jats:p>","DOI":"10.3390\/cancers11111777","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T04:07:07Z","timestamp":1573531627000},"page":"1777","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Health Status in Long-Term Survivors of Hepatoblastoma"],"prefix":"10.3390","volume":"11","author":[{"given":"Bo\u017cenna","family":"Dembowska-Bagi\u0144ska","sequence":"first","affiliation":[{"name":"Department of Oncology, Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wi\u0119ckowska","sequence":"additional","affiliation":[{"name":"Department of Oncology, Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-3066","authenticated-orcid":false,"given":"Agnieszka","family":"Bro\u017cyna","sequence":"additional","affiliation":[{"name":"Department of Oncology, Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"\u015awi\u0119szkowska","sequence":"additional","affiliation":[{"name":"Department of Oncology, Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hor","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery &amp; Organ Transplantation; Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Broniszczak-Czyszek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery &amp; Organ Transplantation; Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Stefanowicz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery &amp; Organ Transplantation; Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142awa","family":"Grajkowska","sequence":"additional","affiliation":[{"name":"Department of Pathology; Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-2229","authenticated-orcid":false,"given":"Piotr","family":"Kalici\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery &amp; Organ Transplantation; Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood High-Risk Hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study","volume":"28","author":"Maibach","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2741\/e392","article-title":"Hepatoblastoma throughout SIOPEL trials-clinical lessons learnt","volume":"4","author":"Czauderna","year":"2012","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hiyama, E., Kurihara, S., Ueda, Y., Hishiki, T., Ida, K., Iehara, T., Watanabe, K., Hoshino, K., Ko, K., and Tanaka, Y. (2019). Late toxicities, especially second malignancies, with GWAS analysis in hepatoblastoma cases treated in the Japanese study group for pediatric liver tumor protocol-2. J. Clin. Oncol., 37.","DOI":"10.1200\/JCO.2019.37.15_suppl.10043"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11606-009-0995-8","article-title":"Chronic Health Conditions in Childhood Cancer Survivors: Is it All Treatment-Related\u2014Or Do Genetics Play a Role?","volume":"24","author":"Armenian","year":"2009","journal-title":"J. Gen. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2018.04.001","article-title":"The influence of genetic variation on late toxicities in childhood cancer survivors: A review","volume":"126","author":"Clemens","year":"2018","journal-title":"Crit. Rev. Hematol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_8","first-page":"S36","article-title":"Cisplatin therapy in infants: Short and long-term morbidity","volume":"18","author":"Brock","year":"1992","journal-title":"Br. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: A consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J. Clin. Oncol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MPH.0b013e31821f0eaf","article-title":"Survival and long-term outcomes in children with Hepatoblastoma treated with continuous infusion of Cisplatin and Doxorubicin","volume":"33","author":"Sivaprakasam","year":"2011","journal-title":"J. Ped. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from Cisplatin-Induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","unstructured":"(2019, June 18). PHITT - University of Birmingham. Available online: https:\/\/www.birmingham.ac.uk."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children\u2019s oncology group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00003446-199810000-00001","article-title":"Children with minimal sensorineural hearing loss: Prevalence, educational performance and functional status","volume":"19","author":"Bess","year":"1998","journal-title":"Ear Hear."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific late mortality among 5-year survivors of childhood cancer: The childhood cancer survivor study","volume":"100","author":"Mertens","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2018.12.021","article-title":"Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960\u20131999 and registered in the Italian Off-Therapy registry","volume":"110","author":"Bagnasco","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-014-0085-1","article-title":"Managing Chemotherapy-Related cardiotoxicity in survivors of childhood cancers","volume":"16","author":"Lipshultz","year":"2014","journal-title":"Paediatr. Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2001.19.1.191","article-title":"Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study","volume":"19","author":"Kremer","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and preventing Anthracycline-Related cardiotoxicity","volume":"38","author":"Armenian","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. B"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnci\/93.8.618","article-title":"Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study","volume":"93","author":"Neglia","year":"2001","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ju, H.Y., Moon, E.K., Lim, J., Park, B.K., Shin, H.Y., Won, Y.J., and Park, H.J. (2018). Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207243"},{"key":"ref_24","unstructured":"(2019, June 19). Hepatoblastoma and Medulloblastoma: Justin\u2019s Story. Available online: https:\/\/www.chop.edu\/stories\/hepatoblastoma-and-medulloblastoma-justin-s-story."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2016.71.6902","article-title":"Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy","volume":"35","author":"Teepen","year":"2017","journal-title":"J Clin Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e27103","DOI":"10.1002\/pbc.27103","article-title":"Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening","volume":"65","author":"Li","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4274\/jcrpe.v1i6.281","article-title":"A rare cause of precocious puberty: Hepatoblastoma","volume":"1","author":"Eren","year":"2009","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/jpem-2014-0167","article-title":"Hepatoblastoma presenting as precocious puberty: A case report","volume":"28","author":"Marino","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00520-010-1080-x","article-title":"Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatment","volume":"20","author":"Brouwer","year":"2012","journal-title":"Support. Care Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1542\/peds.2007-1396","article-title":"Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature","volume":"121","author":"Kaste","year":"2008","journal-title":"Pediatrics"},{"key":"ref_31","first-page":"521","article-title":"Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer","volume":"26","author":"Klap","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00247-017-4050-3","article-title":"Fractures in children with newly diagnosed hepatoblastoma","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr. Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00467-017-3662-z","article-title":"Late renal toxicity of treatment for childhood malignancy: Risk factors, long-term outcomes, and surveillance","volume":"33","author":"Skinner","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_34","first-page":"53","article-title":"Longitudinal study of renal function in pediatric liver transplant recipients","volume":"10","author":"Szymczak","year":"2005","journal-title":"Ann. Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jpedsurg.2011.11.073","article-title":"Changing treatment and outcome of children with hepatoblastoma: Analysis of a single center experience over the last 20 years","volume":"479","author":"Ismail","year":"2012","journal-title":"J. Pediatr. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: International survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"ref_37","first-page":"1967","article-title":"Body-mass index cut-off values for underweight in Dutch children. Ned","volume":"148","author":"Buuren","year":"2004","journal-title":"Tijdschr. Geneeskd."},{"key":"ref_38","unstructured":"Body Mass Index - BMI - WHO\/Europe (2019, July 06). Nutrition. Available online: http:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch. Dis. Child."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: A practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med. Pediatr. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1777\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:36Z","timestamp":1760189616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["cancers11111777"],"URL":"https:\/\/doi.org\/10.3390\/cancers11111777","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}